Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: A systematic review and meta-analysis of randomized controlled trials

AIM: We conducted this systematic review and meta-analysis to investigate the efficacy and safety of gefapixant, a novel P2X3 receptor antagonist, in patients with chronic cough. METHODS: We searched four databases for randomized controlled trials (RCTs). We assessed the cough frequency, severity, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Zaid, Ahmed, Aljaili, Aseel Khalid, Althaqib, Amnah, Adem, Fatima, Alhalal, Doaa Ali, Almubarak, Amena Faiq, Aldughaither, Saud Musaab, Alghabban, Sarah Ali, Alfaraj, Ghaidaa, Masoud, Ahmed Taher, Alsuhaibani, Nujud Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109686/
https://www.ncbi.nlm.nih.gov/pubmed/34012479
http://dx.doi.org/10.4103/atm.ATM_417_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109686/
https://www.ncbi.nlm.nih.gov/pubmed/34012479
http://dx.doi.org/10.4103/atm.ATM_417_20

Ejemplares similares